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ADH1andADH3aremajortwoADHisozymesintheliver,whichparticipateinsystemicalcoholmetabolism,mainlydistributing
in parenchymal and in sinusoidal endothelial cells of the liver, respectively. We investigated how these two ADHs contribute to the
elimination kinetics of blood ethanol by administering ethanol to mice at various doses, and by measuring liver ADH activity
and liver contents of both ADHs. The normalized AUC (AUC/dose) showed a concave increase with an increase in ethanol dose,
inversely correlating with β.C L T (dose/AUC) linearly correlated with liver ADH activity and also with both the ADH-1 and -3
contents (mg/kg B.W.). When ADH-1 activity was calculated by multiplying ADH-1 content by its Vmax/mg (4.0) and normalized
by the ratio of liver ADH activity of each ethanol dose to that of the control, the theoretical ADH-1 activity decreased dose-
dependently, correlating with β. On the other hand, the theoretical ADH-3 activity, which was calculated by subtracting ADH-1
activity from liver ADH activity and normalized, increased dose-dependently, correlating with the normalized AUC. These results
suggested that the elimination kinetics of blood ethanol in mice was dose-dependently changed, accompanied by a shift of the
dominant metabolizing enzyme from ADH 1 to ADH 3.
1.Introduction
Alcohol dehydrogenase (ADH; EC 1.1.1.1) in the liver is
generally accepted to be the primary enzyme responsible for
ethanol metabolism. This is supported by evidence that the
level of liver ADH activity is closely correlated with the rate
of ethanol metabolism [1–3] and that the metabolism in
vivo is markedly depressed in animals treated with pyrazoles
of ADH inhibitors [4, 5] and in ones genetically lacking
ADH [6]. The process by which blood ethanol is eliminated
was traditionally assumed to follow zero-order [7] or single
Michaelis-Menten (M-M) kinetics [8, 9], even though mam-
malian livers actually contain three kinds of ADH isozymes
(Class I, II, III) with diﬀerent Kmsf o re t h a n o l[ 10, 11].
Thus, it was commonly thought that the elimination process
was regulated by Class I ADH (ADH 1), which distributes
mainlyinparenchymallivercells[12],becausethisclassically
known ADH has the lowest Km among the three liver ADH
isozymes and because its activity saturates at millimolar
levels of ethanol. Indeed, mice genetically lacking ADH 1
have been used to demonstrate that ADH 1 is a key enzyme
in systemic ethanol metabolism [13, 14]. However, studies
on these ADH-1-deﬁcient animals have also shown that
ethanol metabolism in vivo cannot be explained solely by
ADH 1 [13, 14]. Although the microsomal ethanol oxidizing
system (MEOS) including CYP2E1 as a main component,
andcatalasehavebeendiscussedformanyyearsascandidates
fornon-ADH1pathways[15,16],thesestudieshavefailedto
clarify their roles in ethanol metabolism in mice genetically
lacking these enzymes [17–19]. Moreover, the process of the
elimination of blood ethanol has been shown to involve ﬁrst-
order kinetics [20–23], suggesting that alcohol-metabolizing
e n z y m e sw i t hav e r yh i g hKm participate in systemic ethanol
metabolism. ADH 3 (Class III), another major ADH, which
distributes mainly in sinusoidal endothelial cells of the liver
[12], has very high Km for ethanol. Therefore, it shows very2 International Journal of Hepatology
little activity when assayed by the conventional method with
millimolar levels of ethanol as a substrate; but its activity
increases up to the molar level of ethanol [10, 24]. Addi-
tionally, this ADH has been demonstrated to be markedly
activated under hydrophobic conditions, which lower its
Km [14, 25]. Previously, liver ADH activity was assumed to
be attributable solely to ADH 1 because it was responsible
for most of the activity due to its low Km [10, 24]. However,
we have used ethanol-treated mice to show that liver ADH
activity assayed by the conventional method depends not
only on ADH 1 but also on ADH 3 and governs the elimi-
nation rate of blood ethanol [3]. Moreover, we have recently
demonstrated using Adh3-null mice that ADH 3 participates
in systemic ethanol metabolism dose-dependently [14].
These data suggest that systemic ethanol metabolism in
miceinvolvesbothliverADH1andADH3,possiblythrough
the regulation of their contents and/or enzymatic kinetics.
However, how these two ADH isozymes contribute to the
elimination kinetics of ethanol is largely unknown.
In the present study, we investigated how these two liver
ADHs contribute to the elimination kinetics of ethanol in
mice by statistically analyzing the pharmacokinetic parame-
ters of blood ethanol and the enzymatic parameters of ADH,
based on a two-ADH model that ascribes liver ADH activity
to both ADH 1 and ADH 3.
2. Methods
2.1. Measurement of Pharmacokinetic Parameters of Blood
Ethanol. As previously described [3], male ddY mice (9
weeks old) were injected with ethanol (i.p.) at a dose of 1,
2, 3, 4.5, or 5g/kg body weight, while the control mice were
injected with saline (0g/kg). For each dose, blood samples
were taken from the tails of mice (n = 3) at scheduled times
(0.5, 1, 2, 4, 8, and 12h) after ethanol administration.
Blood ethanol concentration was measured with a head-
space gas chromatograph [3] .T h er a t eo fe t h a n o le l i m i n a -
tion from blood was expressed as a β-value (mmol/L/h),
which was calculated from a regression line ﬁtted to the
blood ethanol concentrations at various times by the lin-
ear least-squares method [26]. The area under the blood
concentration-time curve (AUC) was calculated by trape-
zoidal integration using the extrapolation of time course
curves to obtain the normalized AUC (AUC/dose) and body
clearance of ethanol (CLT: the reciprocal of the normalized
AUC) [23].
Allanimalsreceivedhumanecareincompliancewithour
institutional guidelines “The Regulations on Animal Exper-
imentation of Nippon Medical School,” which was based on
“The Guidelines of the International Committee on Labora-
tory Animals 1974”.
2.2. Measurement of Liver ADH Parameters. In order to
obtain liver samples, mice were sacriﬁced by cervical dislo-
cation at scheduled times during ethanol metabolism at each
d o s e( 0 . 5 ,1 ,a n d2hf o r1a n d2g / k g ;0 . 5 ,1 ,2 ,4 ,a n d8h
f o r3 g / k g ;0 . 5 ,1 ,2 ,4 ,8 ,a n d1 2 hf o r0 ,4 . 5 ,a n d5 g / k g )
(n = 3 at each time in each dose). Each liver was homog-
enized in 6vol (w/v) of extraction buﬀer (0.5mM NAD,
0.65mMDTT/5mM Tris-HCL, pH 8.5) and centrifuged at
105,000 ×g for 1h to obtain a liver extract.
ADH activity was measured at pH 10.7 by the conven-
tional assay with 15mM ethanol as a substrate, using liver
extract during the times of ethanol metabolism at each dose.
The ADH 1 and ADH 3 contents of liver were measured by
EIA using isozyme-speciﬁc antibodies on the same samples
as those used for ADH activity [3], excluding the samples
at doses of 2 and 4.5g/kg. The ADH activity and content of
liver were expressed in terms of liver weight/kg body weight
because these units are not inﬂuenced by hepatomegaly or
variations in the total liver weight with respect to body
weight. These liver ADH parameters were averaged over
the ethanol-metabolizing time for each dose of ethanol and
termed the liver ADH activity, the liver ADH 1 content, and
the liver ADH 3 content.
The apparent Km and Vmax of ADH activity were
determined from a Lineweaver-Burk plot with ethanol (0.1–
100mM) as a substrate, using liver extracts obtained at 1 and
4h after ethanol administration for all doses (n = 3a te a c h
time in each dose). Vmax is expressed in units/mg of the sum
of the ADH 1 and ADH 3 contents.
2.3. Two-ADH-Complex Model of Liver ADH Activity. The
two-ADH-complexmodel,whichascribesliverADHactivity
to both ADH 1 and ADH 3, is described by the function
[y (ADH activity) = f (ADH 1 activity, ADH 1 content,
ADH 3 activity, ADH 3 content)] for each liver extract. The
Vmax of ADH 1 in liver extract is assumed to be a constant
4.0units/mg, regardless of ethanol dose, because puriﬁed
mouse ADH 1 usually exhibits a relatively constant Vmax of
around 4.0units/mg, a value that was obtained with around
15mM ethanol as a substrate at pH 10.7 [3]. In the complex
model, therefore, ADH 1 activity was calculated from [ADH
1c o n t e n t× 4.0], while ADH 3 activity was assumed to
be [ADH activity − ADH 1 activity] in each liver. These
assumptions are based on two facts: (1) ADH 2 (the third
ADH isozyme in liver) is only responsible for a very small
portionoftotalADHactivityinmiceliver(<3%)[3],and(2)
ADH 3 is activated depending on the conditions of medium
[14, 25]. The calculated ADH 1 and ADH 3 activities were
then averaged over the ethanol-metabolizing time for each
dose of ethanol and normalized by the ratio of the average
liver ADH activity of each ethanol group to that of the
control. These normalized ADH activities were termed the
theoretical ADH 1 and ADH 3 activities. These parameters
were used for statistical analyses and correlation studies.
3. Results
3.1. Eﬀect of Dose on Pharmacokinetics of Blood Ethanol.
Figure 1 shows the time course of blood ethanol concentra-
tion in mice after the administration of ethanol at various
doses. Blood ethanol elimination roughly followed zero-
order or M-M kinetics, reaching a constant Vmax at every
dose of ethanol, as shown by the regression lines ﬁtted to
the blood ethanol concentrations at various times (r2 =
0.996, 0.996, 0.999, 1.000, and 0.945 for doses of 1, 2, 3,International Journal of Hepatology 3
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Figure 1: Time course of blood ethanol concentration in mice after
ethanol administration (i.p.) at various doses. Each plot represents
the mean ± SD of 3 mice.   1g/kg; 2g/kg;  3g/kg; 4.5g/kg;
  5g/kg.
4.5, and 5g/kg, resp.). The β values were 16.9, 16.5, 14.5,
8.7, and 6.9mmol/L/h and the blood ethanol concentrations
extrapolated to a time of zero (C0) were 25.2, 54.1, 74.8,
94.9, and 104.2mM for doses of 1, 2, 3, 4.5, and 5g/kg,
respectively. The β values were almost constant at low
doses (1 and 2g/kg) but decreased when the dose exceeded
2g/kg (r2 = 0.997) (Figure 2(a)). On the other hand, the
normalized AUC (AUC/dose), which negatively correlated
with β (r2 = 0.974) (Figure 2(b)), showed a concave increase
withdose(r2 = 0.991)(Figure 2(a))and,therefore,exhibited
a linear correlation with the square of the dose (r2 = 0.993)
(data not shown). The CLT of ethanol, that is, the reciprocal
of the normalized AUC, decreased dose-dependently along
a concave curve (data not shown). This diﬀered from the
behavior of β, which exhibited a convex decrease.
3.2. Eﬀe c to fE t h a n o lD o s eo nL i v e rA D HP a r a m e t e r s .Liver
ADH activity (the average over the ethanol-metabolizing
time for each ethanol dose) was higher for the 1g/kg dose
(P<0.001), but lower for doses above 2g/kg (P<0.005 for
4.5 and 5g/kg) than that of the control (Figure 3(a)). Liver
ADH 1 content (the average over the ethanol-metabolizing
time) increased for the 1g/kg dose (P<0.0001) but
decreased at higher doses (P<0.05 for 3g/kg, P<0.0001 for
5g/kg). Liver ADH 3 content (the average over the ethanol-
metabolizing time) also increased for the 1g/kg dose (P<
0.0001) and showed no signiﬁcant decrease at higher doses
(Figure 3(b)). Within ethanol groups, liver ADH activity and
liver ADH 1 content decreased dose-dependently (Figures
3(a) and 3(b)), while the ratio of ADH 3 content to ADH 1
content increased dose-dependently (Figure 3(c)). Both the
ADH 1 and ADH 3 contents correlated linearly with liver
ADH activity (r2 = 1.000 for each) (Figure 4). The Vmax/Km
of ADH activity of liver extract increased dose-dependently,
when measured at 1 or 4h after administration of ethanol
(Figure 5).
3.3. Correlation Between Liver ADH Parameters and Phar-
macokinetic Parameters. Although β showed a convex cor-
relation with liver ADH activity, the CLT showed a linear
correlation with that activity (r2 = 0.972) (Figure 6), and
with both liver ADH 1 and ADH 3 contents (r2 = 0.988 and
0.987, resp.) (Figure 7).
3.4. Two-ADH-Complex Model of Liver ADH Activity. Analy-
sisofthedatabasedonthetwo-ADH-complexmodelofliver
ADH activity revealed that the theoretical ADH 1 activity in
the liver decreased dose-dependently, whereas the theoretical
ADH 3 activity increased dose-dependently (r2 = 1.000 for
each) (Figure 8). As shown in Figure 9, the increase in the
ratio of theoretical activities of ADH 3 to ADH 1 correlated
positively with the normalized AUC (r2 = 1.000), but
negatively with β (r2 = 0.984).
4. Discussion
The elimination rate of alcohol from the blood (β) is usually
assumed to be constant regardless of the blood ethanol
level and to correspond to the rate constant of zero-order
or the Vmax of single Michaelis-Menten (M-M) elimination
kinetics [7–9]. However, the present study in mice showed
that β decreased dose-dependently at higher doses (3–5g/kg)
(Figure 2(a)), which was accompanied by a decrease in liver
ADH activity (Figure 3(a)). β was found to be constant only
when liver ADH activity was suﬃciently high at low doses of
ethanol (1 and 2g/kg), in which case the liver ADH activity
was greater than that of the control. These results mean that,
as the ethanol dose increases, the elimination kinetics of
ethanol in mice changes from M-M to other kinetics, which
involves the decrease of liver ADH activity. Similar results
have been reported for rats; β o rt h ec l e a r a n c er a t ed e c r e a s e d
dose-dependently at doses above 2g/kg, accompanied by
dose-dependent decreases of liver ADH activity [27, 28].
AUC, which represents the total amount of ethanol
involved in systemic exposure, is an important pharmacoki-
netic parameter on the bioavailability or toxicity of ethanol.
In the present study, the normalized AUC (AUC/dose)
showedaconcaveincreaseagainstethanoldose(Figure 2(a)),
probably due to the decrease of liver ADH activity at higher
doses of ethanol (Figure 3(a)). Therefore, it showed a linear
correlation with the square of the dose, but not with dose
itself(seeSection 3).Thesedataalsoindicatethatoverawide
rangeofdosestheethanolpharmacokineticsinmicedoesnot
simply follow zero-order [7] or M-M kinetics [9], in which
the relation between the normalized AUC and ethanol dose
shows a proportional correlation.
Several studies have suggested that the elimination of
blood ethanol involves ﬁrst-order kinetics. In humans [29]
and rabbits [23], β gradually increased, even at doses
of 2 or 3g/kg, even though the concentration of blood
ethanol exceeded that at which the activity of ADH 1, the key4 International Journal of Hepatology
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metabolic enzyme, is saturated [10, 24]. This type of elimi-
nation of blood ethanol is probably due to the participation
in ethanol metabolism of higher Km enzyme(s) without a
decrease of liver ADH activity. Fujimiya et al. [23]h a v e
proposed a parallel ﬁrst-order and M-M kinetics for this
type of ethanol elimination, in which the relation between
the normalized AUC and ethanol dose is also linearly
proportional. However, our present results for mice suggest
that, just as in humans and rabbits, β decreases at higher
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doses of ethanol than 3g/kg due to a decrease in liver ADH
activity.
The ﬁrst-order kinetics in alcohol elimination from
the blood has been clearly observed in highly intoxicated
men with several hundred mM of blood ethanol [20, 21].
ADH− deer mice, which have a low liver ADH activity due
to genetically lacking ADH 1 [6], also eliminated blood
ethanol following kinetics similar to ﬁrst-order one up to an
ethanol dose of 6g/kg, at which the maximum blood ethanol
concentration reached around 130mM [30]. These cases of
ethanol elimination are probably carried out by a very high-
Km enzyme rather than the key enzyme of ADH 1.6 International Journal of Hepatology
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subtracting the ADH 1 activity from the total liver ADH activity.
The total liver ADH activity was from Figure 3(a) and liver ADH 1
content from Figure 3(b).T h et h e o r e t i c a lA D H1(  )a n dA D H3
() activities were obtained by normalizing by the ratio of the total
ADH activity to that for the control.
As non-ADH 1 pathways, MEOS and catalase have been
assumed to participate in ethanol metabolism when the
blood ethanol level is high because their Kms for ethanol is
higher than that of ADH 1 [16, 31–33]. However, neither of
these enzymes can explain the ﬁrst-order kinetics observed
at such high levels of blood ethanol in humans and ADH−
deer mice because their activities saturate around 50mM
of ethanol [34, 35]. Moreover, any contributions of these
two enzymes to systemic alcohol metabolism have not been
demonstrated even by using CYP2E1-null or acatalasemic
mouse, which genetically lacks MEOS or catalase activity,
respectively [17–19]. On the other hand, ADH 4, which
mainly localizes in the stomach and also has a higher Km
for ethanol than ADH 1 [36], may play an important role
in ﬁrst-pass metabolism (FPM) to lower BAC and AUC
[37]. However, the eﬀect of FPM on BAC is distinct only
at low doses of ethanol, which becomes unclear at 2g/kg
and more [37, 38]. In addition, ethanol was injected to mice
intraperitoneally in our study. Therefore, the contribution of
A D H4t oB A Ca n dβ value may be negligible in this study.
We have recently proposed the participation of ADH 3,
which has a very high Km for ethanol, as a non-ADH 1
pathway of ethanol metabolism. Experiments on ADH 3−/−
mice showed that ADH 3 dose-dependently contributed to
the elimination of blood ethanol, probably through ﬁrst-
order kinetics [14]. We focused on liver ADH activity and
two ADH isozymes, ADH 1 and ADH 3, to analyze elimina-
tion kinetics of blood alcohol because the total ADH activity
of the liver is closely correlated with the elimination rate
of blood alcohol [1–3] and both ADH isozymes have been
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demonstrated in vivo to contribute to alcohol metabolism
[13, 14].
Although β does not always correlate with total liver
ADH activity when the activity is excessive [39, Figure 6],
bodyclearance(CLT)exhibitedalinearcorrelationwithliver
ADH activity (Figure 6). CLT, which is the reciprocal of the
normalized AUC, is an important parameter indicating the
ethanoleliminationcapacityofthewholebody.Manystudies
have demonstrated that the rate of ethanol elimination in the
whole body (CLT or μmoles/h/animal) correlates with the
total liver ADH activity [1, 2, 28, 40]. However, the ethanol
elimination in the body cannot be explained solely by ADH
1[ 6, 13, 14]. The present study showed that CLT,w h i c h
correlated with liver ADH activity (Figure 6), also correlated
with both contents of ADH 1 and ADH 3 (Figures 4 and 7).
Therefore, it is considered that the capacity to eliminate
ethanol from the whole body involves not only ADH 1 but
also ADH 3, depending primarily on the level of total liver
ADH activity [3].
In the two-ADH-complex model, which ascribes liver
ADH activity to both ADH 1 and ADH 3, the theoreti-
cal ADH 1 activity decreased dose-dependently (Figure 8),
which is experimentally supported by the dose-dependent
decrease in liver ADH 1 content (Figure 3(b)). On the
other hand, the theoretical ADH 3 activity increased dose-
dependently (Figure 8). This is supported by the dose-
dependent increasein theapparentVmax/Km ofADHactivity
of liver extract, which is expressed in units/mg of the sum
of the ADH 1 and ADH 3 contents (Figure 5). The kinetic
activation of liver ADH 3 at large doses of ethanol (3–
5g/kg) was also suggested by our previous study [3]. In
addition, the theoretical ADH 3 activity also correlated with
theratiooftheADH3totheADH1content,whichincreasedInternational Journal of Hepatology 7
dose-dependently (Figure 3(c)). All these experimental data
support the idea that the activity of ADH 3 increases dose-
dependently due to changes in its content and/or enzyme
kinetics in the liver.
The changes in β and the normalized AUC against
ethanol dose, which showed an inverse linear correlation
(Figure 2(b)), may be ascribed to the changes in ADH 1
and ADH 3 activities in the liver (Figure 9). Theoretical
ADH 3 activity and normalized AUC show similar dose-
dependent increases, whereas theoretical ADH 1 activity
and β show similar dose-dependent decreases (Figures 2(a)
and 8). The hypothesis that the increase in ADH 3 activity
accompanying the decrease in ADH 1 activity in the liver
increases the normalized AUC and decreases β (Figure 9)i s
supported by the fact that the ethanol-oxidizing eﬃciency
of ADH 3 is much less than that of ADH 1 due to its low
aﬃnity for ethanol. Thus, the two-ADH-complex model of
liver ADH activity explains well the dose-dependent changes
in the pharmacokinetic parameters in mice. The greater
participationofADH3andthesmallerparticipationofADH
1intoethanolmetabolismincreaseAUC,whichinturnraises
the ratio of ADH 3 activity to ADH 1 activity (Figure 9).
This interdependent increase in the activity ratio and AUC
may elevate the bioavailability or toxicity of ethanol. This
dynamic theory of the elimination kinetics of ethanol based
on the two-ADH-complex model seems to be applicable to
alcoholism; regarding patients with alcoholic liver disease,
we already reported that the ADH 3 activity increased but
the ADH 1 activity decreased with an increase in alcohol
intake. Furthermore, the ratio of ADH 3 to ADH 1 activity
is signiﬁcantly related to the incidence of alcoholic cirrhosis
of the liver [41].
5. Conclusion
The present study suggests that the elimination kinetics
of ethanol in mice changes dose-dependently from M-M
kinetics to ﬁrst-order kinetics due to a shift of the dominant
metabolizing enzyme from low-Km ADH 1 to very high-
Km ADH 3. Such a change in the enzymatic pathway of
ethanol metabolism may elevate the toxicity of ethanol by
nonlinearly increasing AUC due to a decrease in liver ADH
activity and sustaining the metabolism through an increase
inADH3activity.Thus,ADH1andADH3,whichdistribute
mainly in parenchymal cells and in sinusoidal endothelial
cells of the liver, respectively, seem to regulate pathological
eﬀects of alcohol by sharing alcohol metabolism, depending
on their catalytic eﬃciencies, intralobular locations, and
responsive potentials to ethanol dose.
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